HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hanrui Zheng Selected Research

Monoclonal Antibodies

1/2015Cost-effectiveness of RAS screening before monoclonal antibodies therapy in metastatic colorectal cancer based on FIRE3 Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hanrui Zheng Research Topics

Disease

4Neoplasms (Cancer)
01/2022 - 01/2017
2Hepatocellular Carcinoma (Hepatoma)
01/2021 - 04/2020
2Stomach Neoplasms (Stomach Cancer)
01/2021 - 11/2016
2Adenocarcinoma
01/2020 - 11/2016
1Disease Progression
01/2022
1Diabetic Foot
01/2022
1Ulcer
01/2022
1Carcinoma (Carcinomatosis)
01/2022
1Diabetes Mellitus
01/2022
1Esophageal Neoplasms (Esophageal Cancer)
01/2022
1Body Weight (Weight, Body)
01/2021
1Type 2 Diabetes Mellitus (MODY)
01/2021
1Overweight
01/2021
1Obesity
01/2021
1Infections
01/2021
1Nasopharyngeal Carcinoma
02/2020
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2020
1Esophageal Squamous Cell Carcinoma
12/2019
1Parkinson Disease (Parkinson's Disease)
01/2019
1Glioblastoma (Glioblastoma Multiforme)
12/2018
1Adenocarcinoma of Lung
12/2018
1Ovarian Neoplasms (Ovarian Cancer)
12/2018
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2018
1Malignant Mesothelioma
01/2017
1Colorectal Neoplasms (Colorectal Cancer)
01/2015

Drug/Important Bio-Agent (IBA)

3Cisplatin (Platino)FDA LinkGeneric
02/2020 - 11/2016
3Fluorouracil (Carac)FDA LinkGeneric
02/2020 - 11/2016
2Bevacizumab (Avastin)FDA Link
01/2021 - 01/2017
2Sorafenib (BAY 43-9006)FDA Link
01/2021 - 04/2020
2Irinotecan (Camptosar)FDA LinkGeneric
01/2020 - 11/2016
2Leucovorin (Folinic Acid)FDA Link
01/2020 - 11/2016
1Heparin (Liquaemin)FDA LinkGeneric
01/2022
1pembrolizumabIBA
01/2022
1LigandsIBA
01/2022
1avelumabIBA
01/2022
1Hyaluronic Acid (Hyaluronan)IBA
01/2022
1Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
01/2022
1Sodium-Glucose Transporter 2 InhibitorsIBA
01/2021
1SodiumIBA
01/2021
1theasinensin AIBA
01/2021
1atezolizumabIBA
01/2021
1Glucose (Dextrose)FDA LinkGeneric
01/2021
1Fetal Proteins (Fetoprotein)IBA
04/2020
1RamucirumabIBA
04/2020
1GemcitabineFDA Link
02/2020
1Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2020
1olaparibIBA
01/2020
1Pharmaceutical PreparationsIBA
12/2018
1mangiferinIBA
12/2018
1Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2018
1Tyrosine Kinase InhibitorsIBA
01/2018
1Growth Factor ReceptorsIBA
01/2018
1Pemetrexed (MTA)FDA Link
01/2017
1Capecitabine (Xeloda)FDA Link
11/2016
1Epirubicin (Ellence)FDA LinkGeneric
11/2016
1Cetuximab (Erbitux)FDA Link
01/2015
1Monoclonal AntibodiesIBA
01/2015

Therapy/Procedure

6Therapeutics
01/2022 - 01/2015
3Drug Therapy (Chemotherapy)
01/2022 - 01/2018
1Glycemic Control
01/2021
1Neoadjuvant Therapy
12/2019
1Transplantation
01/2019
1Liver Transplantation
01/2019
1Islets of Langerhans Transplantation
01/2019
1Radiotherapy
12/2018